Cargando…

Molecular Alterations of KIT Oncogene in Gliomas

Gliomas are the most common and devastating primary brain tumours. Despite therapeutic advances, the majority of gliomas do not respond either to chemo or radiotherapy. KIT, a class III receptor tyrosine kinase (RTK), is frequently involved in tumourigenic processes. Currently, KIT constitutes an at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gomes, Ana L., Reis-Filho, Jorge S., Lopes, José M., Martinho, Olga, Lambros, Maryou B. K., Martins, Albino, Schmitt, Fernando, Pardal, Fernando, Reis, Rui M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2007
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618227/ https://www.ncbi.nlm.nih.gov/pubmed/17726262 http://dx.doi.org/10.1155/2007/926274

Ejemplares similares

Molecular Characterization of PDGFR-α/PDGF-A and c-KIT/SCF in Gliosarcomas
por: Reis, Rui M., et al.
Publicado: (2005)

Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
por: Martinho, O, et al.
Publicado: (2009)

Genetic characterization of breast cancer and implications for clinical management
por: Geyer, Felipe C, et al.
Publicado: (2009)

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
por: Reis-Filho, Jorge S, et al.
Publicado: (2005)

Overexpression of platelet-derived growth factor receptor α in breast cancer is associated with tumour progression
por: Carvalho, Inês, et al.
Publicado: (2005)

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
por: Elbauomy Elsheikh, Somaia, et al.
Publicado: (2007)

c-myc, not her-2/neu, can predict the prognosis of breast cancer patients: how novel, how accurate, and how significant?
por: Schmitt, Fernando C, et al.
Publicado: (2003)

Silencing of WNK2 is associated with upregulation of MMP2 and JNK in gliomas
por: Costa, Angela Margarida, et al.
Publicado: (2014)

Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas
por: Martinho, Olga, et al.
Publicado: (2012)

Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma
por: Longatto-Filho, Adhemar, et al.
Publicado: (2009)

WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma
por: Gonçalves, Céline S., et al.
Publicado: (2018)

The career survival kit
por: FTPress Delivers
Publicado: (2011)

Nuclear and Nucleolar Image Analysis of Human Breast Epithelial Cells Transformed by benzo[a]pyrene and Transfected with the c-Ha-ras oncogene
por: Barbisan, Luís Fernando, et al.
Publicado: (1998)

Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance
por: Kenicer, Juliet, et al.
Publicado: (2014)

LMTK3 is essential for oncogenic KIT expression in KIT-mutant GIST and melanoma
por: Klug, Lillian R., et al.
Publicado: (2018)

Evaluation of the Expression of C-kit (CD117) in Ependymomas and Oligodendrogliomas
por: Zavalhia, Lisiane Silveira, et al.
Publicado: (2012)

DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes
por: La-Touche, Susannah, et al.
Publicado: (2016)

Determination of HER2 Amplification Status on Tumour DNA by Digital PCR
por: Garcia-Murillas, Isaac, et al.
Publicado: (2013)

Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer
por: Wilkerson, Paul M, et al.
Publicado: (2016)

A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms—Granting a Positive Outcome
por: Vinagre, João, et al.
Publicado: (2020)

Validation of a Fully Automated HER2 Staining Kit in Breast Cancer
por: Moelans, Cathy B., et al.
Publicado: (2010)

Nanomechanics of G-quadruplexes within the promoter of the KIT oncogene
por: Buglione, Enrico, et al.
Publicado: (2021)

Monocarboxylate Transporters 1 and 4 Are Associated with CD147 in Cervical Carcinoma
por: Pinheiro, Céline, et al.
Publicado: (2009)

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
por: Turner, Nicholas, et al.
Publicado: (2010)

Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells
por: Miranda-Gonçalves, Vera, et al.
Publicado: (2017)

Characterization of the Promoter Region of the Human c‐kit Proto‐oncogene
por: Yamamoto, Katsuya, et al.
Publicado: (1993)

KIT oncogene inhibition drives intratumoral macrophage M2 polarization
por: Cavnar, Michael J., et al.
Publicado: (2013)

Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature
por: Linhares, Paulo, et al.
Publicado: (2013)

Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
por: Pinheiro, Céline, et al.
Publicado: (2010)

Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling
por: Raquel-Cunha, Ana, et al.
Publicado: (2019)

Nanoparticle-based bioactive agent release systems for bone and cartilage tissue engineering
por: Monteiro, Nelson, et al.
Publicado: (2015)

Expression of p120-Catenin Isoforms Correlates with Genomic and Transcriptional Phenotype of Breast Cancer Cell Lines
por: Paredes, Joana, et al.
Publicado: (2007)

Pro Tools 8 kit: the complete professional workflow for music production
por: Shimonski, Robert, et al.
Publicado: (2009)

The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions
por: Reis-Filho, Jorge S, et al.
Publicado: (2003)

A Novel Gene RNF138 Expressed in Human Gliomas and Its Function in the Glioma Cell Line U251
por: Zhou, You-xin, et al.
Publicado: (2012)

Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas
por: Saini, Masum, et al.
Publicado: (2012)

Stimulation of Neurite Outgrowth Using Autologous NGF Bound at the Surface of a Fibrous Substrate
por: Casanova, Marta R., et al.
Publicado: (2021)

Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
por: Chong, Irene Yushing, et al.
Publicado: (2018)

Cryo-EM analyses of KIT and oncogenic mutants reveal structural oncogenic plasticity and a target for therapeutic intervention
por: Krimmer, Stefan G., et al.
Publicado: (2023)

Cadherin‐3 is a novel oncogenic biomarker with prognostic value in glioblastoma
por: Martins, Eduarda P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lenbnv4ooi3ql21nc6rlbrvsaf